Subject(s)

Antibodies, Monoclonal, Humanized/administration & dosage , Anticholesteremic Agents/administration & dosage , Aorta/drug effects , Aortic Diseases/drug therapy , Carotid Arteries/drug effects , Carotid Artery Diseases/drug therapy , Dyslipidemias/diagnostic imaging , PCSK9 Inhibitors , Aged , Aorta/diagnostic imaging , Aorta/metabolism , Aortic Diseases/blood , Aortic Diseases/diagnostic imaging , Biomarkers/blood , Carotid Arteries/diagnostic imaging , Carotid Arteries/metabolism , Carotid Artery Diseases/blood , Carotid Artery Diseases/diagnostic imaging , Cholesterol, LDL/blood , Drug Administration Schedule , Dyslipidemias/blood , Dyslipidemias/diagnosis , Female , Fluorodeoxyglucose F18/administration & dosage , Greece , Humans , Inflammation Mediators/blood , Male , Middle Aged , Positron Emission Tomography Computed Tomography , Predictive Value of Tests , Prospective Studies , Radiopharmaceuticals/administration & dosage , Time Factors , Treatment Outcome